“A universal flu vaccine is often referred to as ‘The Holy Grail’ of influenza research, and like the Holy Grail, it is challenging to achieve,” Tamar Ben-Yedidia, chief scientific officer of BiondVax ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing. Influenza causes 140,000 to ...

Australian-American biotech Vaxxas has announced the completion of enrolment for its Phase I avian influenza A (H7N9) vaccine ...

Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an H5N1 bird flu ...

BioNTech and Pfizer have announced that they are initiating a phase 1 study to evaluate a single dose mRNA-based combination vaccine candidate against influenza and COVID-19 – a novel ...

The World Health Oraginzation has a neat little chart called "Pandemic Influenza Phases." It tracks the spread of disease around the globe and emphasizes the level of preparedness necessary to ...

Up to 60 people will be tested in the Phase 2 challenge study, which will provide preliminary data on EV25’s efficacy against influenza and confirm its safety. Data from both the Phase 1 and Phase 2 ...

Our long-acting antiviral influenza preventative, CD388, currently in a 5,000 subject Phase 2b study, shows promise as a new ...